Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Net Income Loss of -$6.12 million for the year ending 2025.
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +84.8% in Net Income Loss from 2024 to 2025.
- This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 19 years of available data (2007 to 2025), ASSEMBLY BIOSCIENCES, INC.'s Net Income Loss has declined by 34.0%.
- Historical annual values: Fiscal year 2025: -$6.12 million | Fiscal year 2024: -$40.18 million | Fiscal year 2023: -$61.23 million | Fiscal year 2022: -$93.09 million | Fiscal year 2021: -$129.86 million | Fiscal year 2020: -$62.15 million | Fiscal year 2019: -$97.63 million | Fiscal year 2018: -$90.75 million | Fiscal year 2017: -$42.81 million | Fiscal year 2016: -$44.26 million | Fiscal year 2015: -$28.45 million | Fiscal year 2014: -$23.79 million | Fiscal year 2013: -$19.40 million | Fiscal year 2012: -$24.79 million | Fiscal year 2011: -$34.34 million | Fiscal year 2010: -$15.29 million | Fiscal year 2009: -$4.54 million | Fiscal year 2008: -$8.79 million | Fiscal year 2007: -$4.57 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: